Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Semaglutide Single Dose Escalation in Healthy Males
NCT03144271Phase 1Completed
- Sponsor
- Novo Nordisk
- Start
- Jun 2007
- Primary completion
- Oct 2007
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Semaglutide with Placebo (2 arms). Primary endpoint: Number of Adverse Events. Started Jun 2007; status: completed.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03144271.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03144271.